✦ LIBER ✦

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

✍ Scribed by Hayes, D.F.; Paoletti, C.

Book ID: 122951437
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 65 KB
Volume: 22
Category: Article
ISSN: 1043-321X
DOI: 10.1016/j.breastdis.2011.03.048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BCL2 in breast cancer: a favourable prog

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

✍ Dawson, S-J; Makretsov, N; Blows, F M; Driver, K E; Provenzano, E; Le Quesne, J; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 578 KB

BCL2 in breast cancer: a favourable prog

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

✍ Dawson, S-J; Makretsov, N; Blows, F M; Driver, K E; Provenzano, E; Le Quesne, J; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 62 KB

Bcl2 is an independent prognostic marker

Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings

✍ Abdel-Fatah, T. M. A.; Perry, C.; Dickinson, P.; Ball, G.; Moseley, P.; Madhusud 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 680 KB

Immunocytochemical localization of BCL-2

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

✍ Julia M. W. Gee; John F. R. Robertson; Ian O. Ellis; Peter Willsher; Richard A. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 824 KB

The protein product of the bcl-2 gene is thought to be involved in inhibition of apoptosis; it may therefore be important in the modulation of hormonal/anti-hormonal responsiveness exhibited by tumours. This study immunocytochemically investigates (i) relationships between bcl-2 protein expression i

Prognostic significance of bcl-2 express

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy

✍ Kyung-Hun Lee; Seock-Ah Im; Do-Youn Oh; Se-Hoon Lee; Eui Kyu Chie; Wonshik Han; 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 282 KB

P55 Prognostic significance of bcl-2 exp

P55 Prognostic significance of bcl-2 expression in stage III breast cancer patients who received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy

✍ S.-A. Im; K.-H. Lee; D.-Y. Oh; W. Han; J.H. Kim; D.-W. Kim; T.-Y. Kim; I.A. Park 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 46 KB